AI-Driven Glucose Biosensing: Dexcom’s (DXCM) Path To A Comeback
Dexcom has become the first company to launch a generative AI-powered continuous glucose monitor.
Posts Tagged ‘NASDAQ:DXCM’
12 Best Weight Loss Stocks to Buy According to Hedge Funds
Most people have at some point sought to include weight loss and physical exercise in their daily life.
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
Wells Fargo’s Best Growth Stocks: 28 Stocks With The Highest Consensus EPS Growth Estimates
With the interest rate cycle kicking off in the US, stocks that are exposed to consumer and business spending are starting to see a favorable economic outlook.
Here’s Why DexCom (DXCM) Declined In Q3
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter 2024 investor letter.
12 High Growth Large Cap Stocks to Buy Now
BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.
DexCom (DXCM) Fell Due to an Uncharacteristic Earnings Miss
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2024 investor letter.
Here’s Why DexCom (DXCM) Detracted in Q3
Investment advisory firm Ithaka Group released the “Ithaka US Growth Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Worst Performing Stocks in S&P 500 in 2024
Since 2023, the market has experienced extended winning streaks, reflecting the economy's resilience.
Multiple Headwinds Dragged DexCom (DXCM) in Q3
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
DexCom, Inc. (NASDAQ:DXCM) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to the DexCom Third Quarter 2024 Earnings Release Conference Call. My name is Abby, and I will be your operator for today's call.
Jim Cramer’s Latest Stock Picks
On Monday, Jim Cramer of Mad Money took a closer look at the market’s recent movements, reassuring investors that rising bond yields shouldn’t cause excessive worry.
10 Worst Performing NASDAQ Stocks in 2024
Markets have been soaring for the better part of the year, with pullbacks acting as entry levels from where investors have joined and pushed the market higher.
10 Best QQQ Stocks to Buy According to Analysts
Several recent discussions have focused solely on the implications of the Fed's recent rate cut for the market.
10 Best Internet of Things (IoT) Stocks to Buy
The Internet of Things (IoT) is a vast network connecting physical objects to the internet.
DexCom (DXCM) Fell Due to Growth Deceleration
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks
The start of October has seen another wild swing for markets.
Jim Cramer’s List of Stocks that Finished Dead Last
In a recent episode of Mad Money, Jim Cramer examined market trends of the third quarter.
7 Best Medical Device Stocks To Buy Right Now
The global medical devices market is experiencing robust growth, driven by technological advancements, an aging population, and an increasing prevalence of chronic diseases.
Here’s Why DexCom (DXCM) Fell in Q2
Investment advisory firm Ithaka Group released the “Ithaka US Growth Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Jim Cramer Wants You to Check These 10 Stocks
Jim Cramer noticed a strange pattern during the recent winning streak last week.
Should You Hold DexCom (DXCM)?
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” second quarter 2024 investor letter.
Does DexCom (DXCM) Have a Long Runway For Growth?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
DexCom, Inc. (NASDAQ:DXCM) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Dexcom Second Quarter 2024 Earnings Release Conference Call. My name is Abby and I'll be your operator for today's call.
Is DexCom (DXCM) Trading at a Discount Now?
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” second quarter 2024 investor letter.
10 Best Growth Stocks To Buy Now According To Billionaire Ray Dalio
Ray Dalio is one of the most successful investors in Wall Street's history.
DexCom, Inc. (NASDAQ:DXCM) Q1 2024 Earnings Call Transcript
DexCom, Inc. beats earnings expectations. Reported EPS is $0.32, expectations were $0.27. DexCom, Inc.
14 Best 52-Week High Stocks To Invest In Now
This article delves into the examination of the 14 best 52-week high stocks to buy now.
5 Best Weight Loss Drug Stocks to Buy Now
In this piece, we will take a look at the five best weight loss drug stocks to buy now.
Should You Hold DexCom (DXCM)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter.
Insiders Are Dumping These 5 Healthcare Stocks
This article presents an overview of Insiders Are Dumping These 10 Healthcare Stocks. For a detailed overview of such stocks, read our article, Insiders Are Dumping These 10...
Here’s What Happened to Dexcom (DXCM) Stock in Q4
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2023 investor letter.
14 Best Medical Device Stocks To Buy Now
In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now.
Should You Hold DexCom (DXCM) for the Long Term?
Next Century Growth Investors, LLC, an investment Management Company, released its “SMID Cap Growth Strategy” fourth-quarter investor letter.
Here’s Why DexCom (DXCM) Outperformed in Q4
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Most Valuable Digital Health Companies In The US
In this article, we will be talking about the 5 most valuable digital health companies in the US.
13 Best Stocks To Buy Before Recessions
In this article, we will take a detailed look at the 13 Best Stocks To Buy Before Recessions. For a quick overview of such stocks, read our article 5 Best Stocks To Buy Before...
15 Best Stocks For Long Term Growth
In this piece, we will look at the 15 best stocks for long-term growth.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
Multiple Factors Pushed DexCom (DXCM) in Q4
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2023 investor letter.
DexCom, Inc. (NASDAQ:DXCM) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to the Dexcom Fourth Quarter and Fiscal Year 2023 Earnings Conference Call.
Here’s Why DexCom (DXCM) Stock Price Rebounded Significantly
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” fourth quarter 2023 investor letter.
Here’s Why DexCom (DXCM) Recovered Rapidly in Q4
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
5 High Growth NASDAQ Stocks That Are Profitable
This article presents an overview of the 5 High Growth NASDAQ Stocks That Are Profitable. For a detailed overview of such stocks, read our article, 14 High Growth NASDAQ ...
5 High Growth Non-Tech Stocks That Are Profitable
This article presents an overview of the 5 High Growth Non-Tech Stocks That Are Profitable. For a detailed overview of such stocks, read our article, 17 High Growth Non-Tech...
Should You Exit DexCom (DXCM)?
ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth quarter 2023 investor letter.
5 Best High Growth Healthcare Stocks to Buy
In this article, we will take a look at the 5 high growth healthcare stocks to buy.
5 High Growth Large-Cap Stocks To Invest In
This article presents an overview of the 5 High Growth Large-Cap Stocks To Invest In. For a detailed overview of such stocks, read our article, 17 High Growth Large-Cap Stocks...
Is DexCom (DXCM) a Worthy Investment?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter.
Should You Hold DexCom (DXCM)?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
